What is the Poisoning Severity Score (PSS) and how is it applied in clinical practice?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Poisoning Severity Score (PSS): Definition and Clinical Application

The Poisoning Severity Score (PSS) is a standardized 5-point grading system (0-4) developed by the International Programme on Chemical Safety, European Commission, and European Association of Poisons Centres and Clinical Toxicologists to assess the severity of acute poisoning based on the most severe clinical features observed. 1

What is the PSS?

The PSS grades poisoning severity as follows:

  • Grade 0: No signs or symptoms
  • Grade 1: Minor symptoms
  • Grade 2: Moderate symptoms
  • Grade 3: Severe, life-threatening symptoms
  • Grade 4: Fatal poisoning

The score evaluates the most severe clinical manifestations during the course of poisoning, not laboratory values or potential risks 1. It was developed through international collaboration involving 14 poison centers across multiple countries, with testing on 371 cases of acute poisoning by various toxic agents 1.

Clinical Applications

Prognostic Value

The PSS demonstrates validated predictive capability for both morbidity and mortality in poisoned patients. In suicidal self-poisoning patients (n=673), higher PSS scores consistently correlated with greater medical morbidity, more intensive acute medical treatments, and nearly all effect sizes were large 2. A 2025 meta-analysis of 60,403 patients across 65 studies found PSS exhibited moderate sensitivity and specificity for mortality prediction, with good discriminatory power 3.

Triage and Resource Allocation

The PSS helps determine:

  • Need for ICU admission: In acute pesticide poisoning, PSS showed the best discriminatory power for predicting ICU admission compared to APACHE II and MEWS 4
  • Follow-up requirements: Initial PSS scoring at telephone inquiry helps identify cases warranting clinical follow-up 5
  • Referral to toxicology specialists: Higher initial scores indicate need for expert consultation 5

Deterioration Prediction

In a prospective study of 718 poison center inquiries, 41 patients deteriorated after initial assessment—31 had initial PSS of 0, demonstrating that even asymptomatic patients require monitoring 5. This highlights a critical caveat: low initial PSS scores do not guarantee benign outcomes.

Important Limitations and Caveats

Subjective Criteria and Misapplication

The PSS has significant practical limitations that restrict its clinical utility. A 2017 systematic review found the PSS is:

  • Time-consuming to score
  • Contains subjective criteria
  • Frequently misapplied or modified from standard scoring
  • Of little use for certain poisoning types 6

Agent-Specific Discordance

The PSS shows poor concordance for specific toxins:

  • Ethanol poisoning: PSS underestimates severity because it doesn't account for blood alcohol concentrations or chronic tolerance. Concordance improved from 72.7% to 92.3% when blood levels were disregarded 7
  • Carbon monoxide: Discrepancies arise from neurological symptom evaluation; PSS doesn't consider COHb levels, lactate, exposure duration, or patient age 7

Limited North American Adoption

There is a paucity of published studies from North America using the PSS, limiting its validation in diverse healthcare systems 6.

Practical Implementation Algorithm

For initial assessment:

  1. Document the most severe clinical features present (not laboratory values)
  2. Assign PSS grade based on clinical manifestations
  3. If PSS 0-1: Arrange follow-up; recognize 75% of deteriorating patients initially had PSS 0 5
  4. If PSS 2: Consider ICU consultation; 2 of 5 deaths had initial PSS 2 5
  5. If PSS 3-4: Immediate intensive care and toxicology consultation 5

For outcome prediction:

  • Combine PSS with agent-specific factors (blood levels for ethanol, COHb for carbon monoxide)
  • Consider APACHE II for mortality prediction in severe cases (comparable performance to PSS) 4
  • Use MEWS for simpler, more feasible ICU admission prediction in organophosphate poisoning 4

Comparative Performance

In the 2025 meta-analysis, MEWS demonstrated the highest sensitivity for mortality prediction, while new-PMS showed the strongest specificity 3. However, PSS remains valuable as a standardized communication tool across poison centers and for epidemiological data collection 1.

The PSS requires follow-up of all cases for accurate grading, though it can be applied at admission if clearly stated 1. Its primary strength lies in providing a common language for severity assessment rather than replacing clinical judgment or agent-specific management protocols.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.